PATENT CLAIM ANALYSIS

Application Number: 16001153
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "134100"]

Abstract:
Methods and compositions for clonally inhibiting or clonally stimulating T-cells are provided.

Claim (Index 79):
A multimeric polypeptide comprising:\n at least one heterodimer comprising: a) a first polypeptide comprising:\n i) a peptide epitope; and \n ii) first major histocompatibility complex (MHC) polypeptide; \n b) a second polypeptide comprising a second MHC polypeptide, and c) at least one immunomodulatory polypeptide wherein the first and/or the second polypeptide comprises the immunomodulatory polypeptide, and wherein the peptide epitope is an epitope present on a cancer cell.

Metadata:
- Claim Count in Document: 60.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14745170', '15040774', '12641095', '11409339', '12138867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.690600761033263
- 35 USC 102 Novelty (BERT): 0.5451064993703355
- Combined Prediction Score: 0.6760513348669702
- Mean Citation Score: 343.35596600000014
- Max Citation Score: 386.52847
- Similarity Product: 304.2611017554784

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test